Pregabalin Population Pharmacokinetic and Exposure‐Response Analyses for Focal Onset Seizures in Children (4–16 years) and Adults, to Support Dose Recommendations in Children

Pregabalin is approved in multiple countries as adjunctive therapy for adult patients with focal onset seizures (FOS; previously termed partial onset seizures). This study used population pharmacokinetic (PK) and exposure–response (E‐R) analyses from pooled pregabalin concentration and efficacy data...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Phylinda L. S., Marshall, Scott F., McFadyen, Lynn, Liu, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359225/
https://www.ncbi.nlm.nih.gov/pubmed/33280106
http://dx.doi.org/10.1002/cpt.2132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359225/
https://www.ncbi.nlm.nih.gov/pubmed/33280106
http://dx.doi.org/10.1002/cpt.2132

Ejemplares similares